Comments
Loading...

eFFECTOR Therapeutics

EFTROTCEM
Logo brought to you by Benzinga Data
$0.00020
0.000.00%
At close: -
$0.0783
0.0839050.00%
After Hours: Jul 5, 4:00 PM EDT

eFFECTOR Therapeutics (OTC:EFTR) Stock Quotes, Forecast and News Summary

eFFECTOR Therapeutics Stock (OTC: EFTR) stock price, news, charts, stock research, profile.

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Rating and Forecast
12345
4.4
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell
Open$0.00
Close$0.00
Volume / Avg.1.67K / 21.90K
Day Range$0.00 - $0.00
52 Wk Range0.00 - 17.75
Market Cap$368.36K
P/E Ratio-
Dividend Yield-
ExchangeOTC
RSI
0
Short Interest-
Days to Cover1

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EFTR

FAQ

Q

How do I buy eFFECTOR Therapeutics (EFTR) stock?

A

You can purchase shares of eFFECTOR Therapeutics (OTCEM:EFTR) through any online brokerage.

View our list of the best stock brokerages

Q

Who are eFFECTOR Therapeutics (EFTR) competitors?

A

There are no as such competitors for eFFECTOR Therapeutics.

Q

What is the forecast, or price target, for eFFECTOR Therapeutics (EFTR) stock?

A

eFFECTOR Therapeutics has a consensus price target of $9.38.

Q

What is the current price for eFFECTOR Therapeutics (EFTR)?

A

The stock price for eFFECTOR Therapeutics (OTCEM: EFTR) is $0.0002 last updated December 24, 2024 at 11:51 AM EST.

Q

Does eFFECTOR Therapeutics (EFTR) pay a dividend?

A

There are no upcoming dividends for eFFECTOR Therapeutics.

Q

When is eFFECTOR Therapeutics (OTCEM:EFTR) reporting earnings?

A

eFFECTOR Therapeutics’s Q1 earnings are confirmed for Thursday, May 9, 2024.

Q

Is eFFECTOR Therapeutics (EFTR) going to split?

A

There is no upcoming split for eFFECTOR Therapeutics.

Q

What sector and industry does eFFECTOR Therapeutics (EFTR) operate in?

A

eFFECTOR Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the OTCEM.